Funder: American Association for Cancer Research
Due Dates (Anticipated): May 2026 (Letter of Intent) | June 2026 (Full application) | September 2026 (Full application, invited applicants)
Funding Amounts: $350,000 total over 3 years; supports PI salary, research staff, supplies, equipment, limited travel, and indirect costs (up to 10%).
Summary: Supports independent investigators advancing Tumor Treating Fields (TTFields) research in cancer, emphasizing mechanistic and translational studies using the Inovitro® system.
Key Information: All deadlines are anticipated/projected; check the program page for updates.